Anavex Life Sciences Corp (AVXL)
3.80
-0.09
(-2.31%)
USD |
NASDAQ |
May 10, 13:34
Anavex Life Sciences Cash from Operations (TTM): -29.31M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -29.31M |
September 30, 2023 | -27.78M |
June 30, 2023 | -25.98M |
March 31, 2023 | -25.38M |
December 31, 2022 | -26.53M |
September 30, 2022 | -24.24M |
June 30, 2022 | -27.87M |
March 31, 2022 | -28.34M |
December 31, 2021 | -26.01M |
September 30, 2021 | -30.38M |
June 30, 2021 | -28.96M |
March 31, 2021 | -25.49M |
December 31, 2020 | -23.43M |
September 30, 2020 | -21.29M |
June 30, 2020 | -17.57M |
March 31, 2020 | -21.02M |
December 31, 2019 | -20.09M |
September 30, 2019 | -18.53M |
June 30, 2019 | -20.05M |
March 31, 2019 | -14.63M |
December 31, 2018 | -13.12M |
September 30, 2018 | -12.58M |
June 30, 2018 | -10.72M |
March 31, 2018 | -11.61M |
December 31, 2017 | -9.484M |
Date | Value |
---|---|
September 30, 2017 | -9.017M |
June 30, 2017 | -8.689M |
March 31, 2017 | -7.938M |
December 31, 2016 | -9.143M |
September 30, 2016 | -9.237M |
June 30, 2016 | -8.807M |
March 31, 2016 | -8.013M |
December 31, 2015 | -6.781M |
September 30, 2015 | -4.227M |
June 30, 2015 | -3.710M |
March 31, 2015 | -3.240M |
December 31, 2014 | -2.918M |
September 30, 2014 | -2.659M |
June 30, 2014 | -2.227M |
March 31, 2014 | -1.299M |
December 31, 2013 | -1.081M |
September 30, 2013 | -0.7776M |
June 30, 2013 | -0.545M |
March 31, 2013 | -0.7515M |
December 31, 2012 | -0.7364M |
September 30, 2012 | -1.693M |
June 30, 2012 | -2.364M |
March 31, 2012 | -3.331M |
December 31, 2011 | -3.806M |
September 30, 2011 | -3.802M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-30.38M
Minimum
Sep 2021
-17.57M
Maximum
Jun 2020
-24.64M
Average
-25.49M
Median
Mar 2021
Cash from Operations (TTM) Benchmarks
Ventyx Biosciences Inc | -166.52M |
Checkpoint Therapeutics Inc | -47.59M |
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |